These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 18298484)

  • 1. Fluticasone and ibuprofen do not add to the effect of salmeterol on organic dust-induced airway inflammation and bronchial hyper-responsiveness.
    Strandberg K; Ek A; Palmberg L; Larsson K
    J Intern Med; 2008 Jul; 264(1):83-94. PubMed ID: 18298484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salmeterol does not alter increased bronchial responsiveness caused by organic dust exposure.
    Ek A; Palmberg L; Sundblad BM; Larsson K
    Chest; 2005 Oct; 128(4):3038-47. PubMed ID: 16236984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
    Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
    Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
    Yates DH; Worsdell M; Barnes PJ
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils.
    Koopmans JG; Lutter R; Jansen HM; van der Zee JS
    J Allergy Clin Immunol; 2005 Nov; 116(5):1007-13. PubMed ID: 16275368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma.
    Fardon T; Haggart K; Lee DK; Lipworth BJ
    Respir Med; 2007 Jun; 101(6):1218-28. PubMed ID: 17178217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of salmeterol/fluticasone propionate combination on airway hyper-responsiveness in patients with well-controlled asthma.
    Chanez P; Stallaert R; Reznikova E; Bloemen P; Adamek L; Joos G
    Respir Med; 2010 Aug; 104(8):1101-9. PubMed ID: 20452196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fluticasone propionate-salmeterol therapy on seasonal changes in airway responsiveness and exhaled nitric oxide levels in patients with pollen-induced asthma.
    Prieto L; Gutiérrez V; Pérez-Francés C; Badiola C; Lanuza A; Bruno L; Ferrer A
    Ann Allergy Asthma Immunol; 2005 Nov; 95(5):452-61. PubMed ID: 16312168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bronchodilator effect of salmeterol and inhibition of bronchial hyperreactivity].
    Boulet LP
    Rev Mal Respir; 1992; 9 Suppl 1():R11-3. PubMed ID: 1350363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma.
    Taylor DA; Jensen MW; Aikman SL; Harris JG; Barnes PJ; O'Connor BJ
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1731-7. PubMed ID: 9412548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ozone on normal and potentially sensitive human subjects. Part II: Airway inflammation and responsiveness to ozone in nonsmokers and smokers.
    Frampton MW; Morrow PE; Torres A; Voter KZ; Whitin JC; Cox C; Speers DM; Tsai Y; Utell MJ
    Res Rep Health Eff Inst; 1997 Jun; (78):39-72; discussion 81-99. PubMed ID: 9387196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma.
    Boulet LP; Franssen E
    Respir Med; 2007 Nov; 101(11):2240-7. PubMed ID: 17686624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of fluticasone on the airway inflammatory response to organic dust.
    Ek A; Palmberg L; Larsson K
    Eur Respir J; 2004 Oct; 24(4):587-93. PubMed ID: 15459137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intranasal fluticasone and salmeterol on allergen-induced nasal responses.
    Parameswaran K; Fanat A; O'Byrne PM
    Allergy; 2006 Jun; 61(6):731-6. PubMed ID: 16677243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of interleukin 13 on bronchial hyperresponsiveness and the bronchoprotective effect of beta-adrenergic bronchodilators and corticosteroids.
    Townley RG; Gendapodi PR; Qutna N; Evans J; Romero FA; Abel P
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):190-7. PubMed ID: 19354064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations.
    Ferguson GT; Anzueto A; Fei R; Emmett A; Knobil K; Kalberg C
    Respir Med; 2008 Aug; 102(8):1099-108. PubMed ID: 18614347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 24 h duration of bronchodilator action of the salmeterol/fluticasone combination inhaler.
    Masoli M; Weatherall M; Ayling J; Williams M; Beasley R
    Respir Med; 2005 May; 99(5):545-52. PubMed ID: 15823450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit from anti-inflammatory treatment during clinical remission of atopic asthma.
    van den Toorn LM; Prins JB; de Jongste JC; Leman K; Mulder PG; Hoogsteden HC; Overbeek SE
    Respir Med; 2005 Jun; 99(6):779-87. PubMed ID: 15878496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone.
    Kurashima K; Hara K; Yoneda K; Kanauchi T; Kagiyama N; Tokunaga D; Takayanagi N; Ubukata M; Sugita Y
    Respirology; 2009 Mar; 14(2):239-44. PubMed ID: 19210650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of low-dose inhaled fluticasone on airway response and inflammation in mild asthma.
    Boulet LP; Turcotte H; Prince P; Lemière C; Olivenstein R; Laprise C; Larivée P; Bégin P; Laviolette M
    Respir Med; 2009 Oct; 103(10):1554-63. PubMed ID: 19692221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.